Efficacy and safety of tolebrutinib versus placebo in non-relapsing secondary progressive multiple sclerosis: results from the Phase 3 HERCULES trial - Fox, R; Bar-Or, A; Traboulsee, A
Presented at: 2024 ECTRIMS O136